AOD9604
A short fragment of human growth hormone (residues 177-191) that was sold the lipolytic tail of HGH without the growth signal. The marketing outpaced the trial data by a wide margin.
Choose an option
- Pay with Bitcoin
- Discreet shipping within Germany
- Purity-guaranteed batches
- 14-day refund period if unsatisfied
Delivery & guarantee
Orders typically arrive within 3 weeks.
If your delivery arrives late, you'll receive a discount on your next order.
About
AOD9604 is a 15-amino-acid tail-end of HGH that Metabolic Pharmaceuticals took into Phase 2 obesity trials in the 2000s. The pitch was elegant: keep the fat-burning bit of growth hormone, strip the IGF-1 arm, and you get a lean-out tool with none of the carpal tunnel or glucose problems.
Read the full research guideWhy people choose it
- Mild support for fat oxidation when paired with fasted morning training
- No appetite suppression and no growth-hormone-like side effects (no carpal tunnel, no insulin sensitivity issues at clinical doses)
- Daily microdosing is well tolerated; injection-site reactions are uncommon
- Reasonable adjunct in a stack with appetite-suppression tools like Semaglutide where the lipolytic arm is genuinely missing
At a glance
- Experience level
- Beginner-friendly
- Administration
- Subcutaneous
Sold for laboratory research only. Not for human consumption. No therapeutic claims are made.
Sign in to view this product
AOD9604
Log in or create a free account to see full details and prices.
Don't have an account? Sign up